Marinus Pharmaceuticals | Capitale Ordinario



Capitale Ordinario Cambiamento Data
Acadia Pharmaceuticals USD 168.71M 104K 2025-09
ALKERMES USD 165.1M 49K 2025-09
Amgen USD 539M 1000K 2025-12
Biogen USD 146.7M 200K 2025-09
Eisai JPY 282.11M 1000 2025-12
Enanta Pharmaceuticals USD 212K 1000 2023-12
Esperion Therapeutics USD 112K 11K 2023-09
Gilead Sciences USD 1.24B 1000K 2025-12
Incyte USD 196.13M 2.01M 2025-09
Minerva Neurosciences USD 1000 0 2024-09
Neurocrine Biosciences USD 100.1M 400K 2025-12
PTC Therapeutics USD 79.93M 554K 2025-09
Regeneron Pharmaceuticals USD 105.3M 1.1M 2025-09
Sarepta Therapeutics USD 104.77M 7.06M 2025-09
Supernus Pharmaceuticals USD 57.12M 1000K 2025-09
UCB EUR 584M 0 2024-12
Vertex Pharmaceuticals USD 254M 0 2025-12


Marinus Pharmaceuticals Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.